首页> 外文会议>Annual International Meeting of the American Society of Agricultural and Biological Engineers >A Novel Method for Microencapsulation of Protein Using High-voltage Electrostatic Field System
【24h】

A Novel Method for Microencapsulation of Protein Using High-voltage Electrostatic Field System

机译:一种使用高压静电场系统微型蛋白质微胶囊的新方法

获取原文

摘要

Protein and peptide based bio-pharmaceuticals and nutraceuticals have been developed in recent years. However, since such products, unlike traditional small-molecule drugs, may not be administered orally, injection or infusion is normally required. There is a need of encapsulation of such proteins or peptide in biodegradable polymeric materials to improve current delivery methods. Conventional microencapsulation methods, such as spray-drying, phase separation, and emulsion techniques, have many disadvantages including thermal and chemical degradation of products, problems of a large amount of solvent used and its disposal, solvent residues, and broad particle size distribution. This research was to develop a new method of high-voltage electrostaticfield for preparing microcapsules of protein. The bovine serum albumin (BSA) was used as the core material while sodium alginate (NaAIg) was used as the carrier. Influences of the ratio of core to carrier and pH on the ratio of retention and loading BSAwere studied. The sizes of microcapsules ranging from 5 to 95 urn in diameter were obtained and eighty percent of the particles distributed between 10 and 60um. Under the optimum microencapsulation conditions, voltage of3.0~4.OkV, distance of 2.5 cm, NaAIg concentration of 2%, and flow rate of 8 ml/h. Chitosan (CS) with different concentrations was used for prolonging release time of BSA. The obtained maximum release time of BSA was 80 hours. It was concluded that high-voltage electrostatic field is aneffective method for preparing the microcapsules of protein and peptide based Pharmaceuticals and nutraceuticals.
机译:近年来开发了蛋白质和肽的生物药物和营养保健品。然而,由于这种产品与传统的小分子药物不同,可能不会口服给药,通常需要注射或输注。需要在可生物降解的聚合物材料中封装这种蛋白质或肽,以改善电流递送方法。常规的微胶囊化方法,例如喷雾干燥,相分离和乳液技术,具有许多缺点,包括产品的热和化学降解,使用大量溶剂的问题及其处理,溶剂残留物和宽粒度分布。该研究是开发一种新的用于制备蛋白质微胶囊的高压静电领域的方法。牛血清白蛋白(BSA)用作芯材,同时使用藻酸钠(NAAIG)作为载体。核心与载体比例的影响和对载体比例研究的影响。获得直径5至95瓮的微胶囊的尺寸,并获得80%的颗粒,分布在10至60um之间。在最佳的微胶囊化条件下,电压为3.0〜4.kV,距离2.5厘米,Naaig浓度为2%,流速为8毫升/小时。具有不同浓度的壳聚糖(CS)用于延长BSA的释放时间。获得的BSA的最大释放时间为80小时。得出结论,高压静电场是制备蛋白质和肽的药物和营养保健品的微胶囊的无效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号